Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are among the most common therapeutic agents used in medical practice, yet their mechanisms of action are only partly understood. This review summarizes our understanding of how glucocorticoids inhibit inflammation and give rise to side effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NLRP3 inflammasome upregulation and caspase-mediated cleavage of the glucocorticoid receptor can cause resistance to the effects of glucocorticoids, which are among the most potent anti-inflammatory hormones in the body46,47.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [47]
In the citing paper
“HPA axis activation and subsequent secretion of glucocorticoids in response to stressor exposure typically acts to prevent pro-inflammatory activity via inhibition of NFκB (Rhen and Cidlowski, 2005).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Rhen and Cidlowski, 2005
In the citing paper
“cortisol is one of the most potent anti-inflammatory hormones in the body.9”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“major depression is a disorder that is characterized by hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis and increased release of glucocorticoids”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“Corticosteroids (e.g., methylprednisolone, prednisolone, prednisone) are commonly used immunosuppressants for their global inhibitory effects on innate and adaptive immunity (36).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [36]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Retracted: Effects of Vitamin K2 on Osteoporosis
Iwamoto, J., Takeda, T., & Satō, Y. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383782 · Cited by 66
RetractedAngus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Epidemiology and estimated population burden of selected autoimmune diseases in the United States
Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4412 · Cited by 1,667
Regulation of matrix metalloproteinases: An overview
Chakraborti, S., Mandal, M., Das, S., Mandal, A., & Chakraborti, T. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1026028303196 · Cited by 1,128
Neuroendocrine Regulation of Immunity
Webster, J. I., Tonelli, L., & Sternberg, E. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.082401.104914 · Cited by 957
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Research works printed but not linked: 4
- Rhen T, Cidlowski JA. Steroid hormone action. In: Strauss JF III, Barbieri RL, eds. Yen and Jaffe's reproductive endocrinology. 5th ed. Philadelphia: Elsevier Saunders, 2004:155-74.
- 10.1210/mend.15.7.0667 · doi:10.1210/mend.15.7.0667 · Paper page
- Roviezzo F, 2002, J Physiol Pharmacol, 53, 541
- Mitch WE, 2000, Trans Am Clin Climatol Assoc, 111, 258
Cited by
Items 201–300 of 1,016
State of the art opioid-sparing strategies for post-operative pain in adult surgical patients
Gabriel, R. A., Swisher, M. W., Sztain, J. F., Furnish, T. J., Ilfeld, B. M., & Said, E. T. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1583743 · Cited by 155
“involve tumor necrosis factor-alpha, interleukin 1B, and c-reactive protein [100].”
BackgroundPatel, S. S., & Savjani, J. (2015) · The Journal of Phytopharmacology · doi:10.31254/phyto.2015.4212 · Cited by 189
“However, they have adverse effects such as immunosuppression, hypertension, osteoporosis, and metabolic disturbances.(4) All these harmful properties contraindicate prolonged glucocorticoid therapy.”
BackgroundRussell, R. J., Boulet, L., Brightling, C. E., Pavord, I. D., Porsbjerg, C. M., Dorscheid, D., & Sverrild, A. (2024) · European Respiratory Journal · doi:10.1183/13993003.01397-2023 · Cited by 172
Nicolaides, N. C., Charmandari, E., Kino, T., & Chrousos, G. P. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00070 · Cited by 145
“Nat Rev Endocrinol (2009) 5(7):374–81.”
Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation
Miller, A. H., Haroon, E., & Felger, J. C. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.167 · Cited by 152
Regulation of innate immune response by MAP kinase phosphatase-1
Wang, X., & Liu, Y. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.03.013 · Cited by 153
Himes, B. E., Jiang, X., Wagner, P., Hu, R., Wang, Q., Klanderman, B. J., Whitaker, R. M., Duan, Q., Lasky-Su, J. A., Nikolos, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099625 · Cited by 183
“Due to their widespread use in the treatment of various inflammatory diseases and the notoriety of their undesirable side effects, GCs have been extensively characterized for their effects on specific tissues [3,34].”
BackgroundNeuro-Behcet's disease: An update on diagnosis, differential diagnoses, and treatment
Borhani‐Haghighi, A., Kardeh, B., Banerjee, S., Yadollahikhales, G., Safari, A., Sahraian, M. A., & Shapiro, L. S. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101906 · Cited by 169
Alternative Translation Initiation in Rat Brain Yields K2P2.1 Potassium Channels Permeable to Sodium
Thomas, D., Plant, L. D., Wilkens, C. M., McCrossan, Z. A., & Goldstein, S. A. N. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.016 · Cited by 165
“ATI of glucocorticoid and fibroblast growth factor 2 (FGF-2) receptors varies across tissues to yield functionally different isoforms important to their physiological function (Touriol et al., 2003; Lu and Cidlowski, 2005; Rhen and Cidlowski, 2005).”
Graversen, J. H., Svendsen, P., Dagnæs-Hansen, F., Dal, J., Anton, G., Etzerodt, A., Petersen, M. D., Christensen, P. A., Møller, H. J., & Moestrup, S. K. (2012) · Molecular Therapy · doi:10.1038/mt.2012.103 · Cited by 144
van der Goes, M. C., Jacobs, J. W. G., & Bijlsma, J. W. J. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4686 · Cited by 163
“Mechanisms of action Th e eff ects of glucocorticoids are thought to be mediated by diff erent mechanisms [14-19].”
BackgroundCircadian Clocks, Stress, and Immunity
Dumbell, R., Matveeva, O., & Oster, H. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00037 · Cited by 171
“Nevertheless, glucocorticoids are still the most widely used and most effective treatment to control allergic, autoimmune, inflammatory, and hematological disorders (63).”
BackgroundThe burden of community-acquired bacterial pneumonia in the era of antibiotic resistance
Peyrani, P., Mandell, L. A., Torres, A., & Tillotson, G. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2019.1562339 · Cited by 165
“response associated with pneumonia [143,144] However, multiple randomized trials and meta-analyses investigating their use”
BackgroundGlucocorticoid-Induced Apoptosis of Healthy and Malignant Lymphocytes
Smith, L. K., & Cidlowski, J. A. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)82001-1 · Cited by 144
“1) (Hermoso and Cidlowski, 2003; Rhen and Cidlowski, 2005).”
BackgroundInfluentialSelf-citationSalter, M., Biggadike, K., Matthews, J. L., West, M. R., Haase, M. V., Farrow, S. N., Uings, I., & Gray, D. W. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00108.2007 · Cited by 158
“GLUCOCORTICOIDS ARE COMMONLY used to treat a wide range of inflammatory conditions such as asthma, allergic rhinitis, chronic obstructive pulmonary disease, rheumatoid arthritis, inflammatory bowel disease, and autoimmune diseases (15).”
BackgroundMethodInfluentialRamamoorthy, S., & Cidlowski, J. A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01151-12 · Cited by 146
“Clinically, synthetic glucocorticoids are employed for the treatment of numerous inflammatory conditions, including ectopia, dermatitis, allergies and asthma, osteoarthritis, adrenal insufficiency, autoimmune disorders, and organ rejection (3).”
BackgroundSelf-citationAl-Harbi, N. O., Imam, F., Al‐Harbi, M. M., Ansari, M. A., Zoheir, K. M. A., Korashy, H. M., Sayed‐Ahmed, M. M., Attia, S. M., Shabanah, O. A., & Ahmad, S. F. (2016) · Immunological Investigations · doi:10.3109/08820139.2016.1157814 · Cited by 146
“Glucocorticoids, such as DEX, are potent anti-inflammatory drugs frequently prescribed for the treatment of various inflammatory diseases, including asthma, chronic obstructive pulmonary disease, and acute respiratory distress syndrome (Joyce et al., 2001; Saklatvala, 2002; Rhen & Cidlowski, 2005).”
Backgroundβ2-Adrenergic receptors in immunity and inflammation: Stressing NF-κB
Kolmus, K., Tavernier, J. H., & Gerlo, S. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.10.007 · Cited by 158
Mechanistic Aspects of Inflammation and Clinical Management of Inflammation in Acute Gouty Arthritis
Cronstein, B. N., & Sunkureddi, P. R. (2013) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e31827d8790 · Cited by 160
“Target genes involved in transrepression include those encoding for a broad range of inflammatory cytokines, enzymes, receptors, and adhesion molecules, notably, IL1A, IL-2, IL-3, IL-4, IL-5, IL-6, IL-8, IL-12, COX-2, E-selectin, and TNF->.77,78 In addition, glucocorticoids can suppress inflammation through transactiv…”
BackgroundInfluentialTHE MEDICAL MANAGEMENT OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA: CURRENT TREATMENT CONSIDERATIONS
Kaplan, F. S., & Disorders, R. (2011) · Cited by 145
‘Endocrine NAFLD’ a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis
Lonardo, A., Carani, C., Carulli, N., & Loria, P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.03.005 · Cited by 149
“[7] Rhen T, Cidlowski JA.”
BackgroundA Membrane Transporter Is Required for Steroid Hormone Uptake in Drosophila
Okamoto, N., Viswanatha, R., Bittar, R., Li, Z., Haga-Yamanaka, S., Perrimon, N., & Yamanaka, N. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.09.012 · Cited by 144
“In mammals, glucocorticoids are primary stress hormones that regulate immune response and energy homeostasis (Sapolsky et al., 2000; Rhen and Cidlowski, 2005; Oakley and Cidlowski, 2011), and gonadal steroids control sexual maturation and reproduction (Sisk and Foster, 2004; Wilson and Davies, 2007).”
Myricanol rescues dexamethasone-induced muscle dysfunction Via a sirtuin 1-dependent mechanism
Shen, S., Liao, Q., Liu, J., Pan, R., Lee, S. M., & Lin, L. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12393 · Cited by 142
“Glucocorticoids (GCs) are widely used as anti-inflammatory and immunosuppressive agents.(3) Skeletal muscle wasting is one of the adverse effects of high dose or the sustained usage of GCs, and it also occurs when the endogenous GCs are increased under stressful conditions, such as sepsis and cachexia.”
BackgroundInhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells
Weichhart, T., Haidinger, M., Katholnig, K., Kopecky, C., Poglitsch, M., Lassnig, C., Rosner, M., Zlabinger, G. J., Hengstschläger, M., Müller, M., et al. (2011) · Blood · doi:10.1182/blood-2010-09-310888 · Cited by 141
“Inhibition of mTOR augments the activation of NF-κB(27), while dexamethasone has potent inhibitory effects on NF-κB activity.(41,42) Therefore, we examined whether mTOR and the GR might reciprocally interact with NF-κB.”
Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons
Hussain, M., & Liu, G. (2024) · Cells · doi:10.3390/cells13050384 · Cited by 164
Social neuroscience: challenges and opportunities in the study of complex behavior
Cacioppo, J. T., & Decety, J. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05858.x · Cited by 136
Koh, I. J., Chang, C. B., Lee, J. H., Jeon, Y.-T., & Kim, T. K. (2013) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-013-3032-5 · Cited by 141
“Fourth, despite the numerous potential side effects associated with corticosteroids [22, 45, 46], we assessed only the incidence of postoperative wound complications because they are the most serious complication associated with TKA.”
BackgroundFilled carbon nanotubes in biomedical imaging and drug delivery
Martinčić, M., & Tobías, G. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.971751 · Cited by 150
“2 Other drugs Dexamethasone is used mainly as an anti-inflammatory and immunosuppressant drug [86].”
BackgroundMechanisms and treatments for severe, steroid‐resistant allergic airway disease and asthma
Hansbro, P. M., Kim, R., Starkey, M. R., Donovan, C., Dua, K., Mayall, J., Liu, G., Hansbro, N. G., Simpson, J. L., Wood, L. G., et al. (2017) · Immunological Reviews · doi:10.1111/imr.12543 · Cited by 145
Exploring the Molecular Mechanisms of Glucocorticoid Receptor Action from Sensitivity to Resistance
Ramamoorthy, S., & Cidlowski, J. A. (2013) · Endocrine Development · doi:10.1159/000342502 · Cited by 134
“The anti-inflammatory and immunomodulatory properties underlie the use of glucocorticoids in the clinic where they are used to treat inflammatory diseases and oncological disorders [1].”
BackgroundInfluentialSelf-citationPleyer, U., Ursell, P. G., & Rama, P. (2013) · Ophthalmology and Therapy · doi:10.1007/s40123-013-0020-5 · Cited by 139
“Corticosteroids mediate their antiinflammatory effects primarily through the glucocorticoid receptor by direct and indirect actions at the genomic level [14].”
BackgroundWellnitz, O., & Bruckmaier, R. M. (2021) · Journal of Dairy Science · doi:10.3168/jds.2020-20029 · Cited by 143
Dual Role for Glucocorticoids in Cardiomyocyte Hypertrophy and Apoptosis
Ren, R., Oakley, R. H., Cruz-Topete, D., & Cidlowski, J. A. (2012) · Endocrinology · doi:10.1210/en.2012-1563 · Cited by 133
Self-citationControl of local immunity by airway epithelial cells
Weitnauer, M., Mijošek, V., & Dalpke, A. H. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.126 · Cited by 160
Galliher-Beckley, A. J., Williams, J. G., Collins, J. B., & Cidlowski, J. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00808-08 · Cited by 136
Self-citationLncRNA GAS5 suppresses ovarian cancer by inducing inflammasome formation
Li, J., Yang, C., Li, Y., Chen, A., Li, L., & You, Z. (2018) · Bioscience Reports · doi:10.1042/bsr20171150 · Cited by 146
Glucocorticoids Induce Osteocyte Apoptosis by Blocking Focal Adhesion Kinase-mediated Survival
Plotkin, L. I., Manolagas, S. C., & Bellido, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611435200 · Cited by 132
Sato, A. Y., Cregor, M., Delgado-Calle, J., Condon, K. W., Allen, M. R., Peacock, M., Plotkin, L. I., & Bellido, T. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2869 · Cited by 130
“Glucocorticoids, producedand releasedby theadrenalglands in response tobiological stress, regulate numerous physiological processes in awide range of tissues.((2,3)) Exaggerated production of glucocorticoids is found in patients with pituitary tumors producing adrenocorticotropin hormone (ACTH) (Cushing’s disease), or…”
BackgroundThe Immune System and the Role of Inflammation in Perinatal Depression
Leff, P., Mancilla‐Herrera, I., Flores‐Ramos, M., Cruz-Fuentes, C. S., Reyes‐Grajeda, J. P., García-Cuétara, M. D. P., Bugnot-Pérez, M. D., & Pulido-Ascencio, D. E. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0048-3 · Cited by 139
The Microbiota-Inflammasome Hypothesis of Major Depression
Inserra, A., Rogers, G. B., Licinio, J., & Wong, M. (2018) · BioEssays · doi:10.1002/bies.201800027 · Cited by 134
The Gut Microbiome Regulates Psychological-Stress-Induced Inflammation
Xu, C., Lee, S. K., Zhang, D., & Frenette, P. S. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.025 · Cited by 134
“That glucocorticoids would promote VOE was unexpected since high dose glucocorticoids are powerful anti-inflammatory drugs (Rhen and Cidlowski, 2005).”
BackgroundRefractory asthma: mechanisms, targets, and therapy
Trevor, J. L., & Deshane, J. S. (2014) · Allergy · doi:10.1111/all.12412 · Cited by 130
“The latter two work as anti-inflammatory proteins with MKP-1 functioning as an inhibitor of MAPK pathways which promote the transcription of pro-inflammatory genes (43, 45).”
BackgroundSpecificity and sensitivity of glucocorticoid signaling in health and disease
Cain, D. W., & Cidlowski, J. A. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.04.007 · Cited by 127
Self-citationThe neuroimmune response during stress: A physiological perspective
Haykin, H., & Rolls, A. (2021) · Immunity · doi:10.1016/j.immuni.2021.08.023 · Cited by 121
“In contrast, stress induced mediators such as the neurotransmitter, noradrenaline or glucocorticoids, common stress hormones, induce immune suppression and in fact, glucocorticoids are used as an immunosuppressant for the treatment of these same conditions (Rhen and Cidlowski, 2005).”
BackgroundTreatments for Corneal Neovascularization: A Review
Gupta, D., & Illingworth, C. (2011) · Cornea · doi:10.1097/ico.0b013e318201405a · Cited by 138
Adcock, I. M., & Mumby, S. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_98 · Cited by 131
Glucocorticoid-Induced Leucine Zipper Is Protective in Th1-Mediated Models of Colitis
Cannarile, L., Cuzzocrea, S., Santucci, L., Agostini, M., Mazzon, E., Esposito, E., Muià, C., Coppo, M., Paola, R. D., & Riccardi, C. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.024 · Cited by 131
Kim, W.-Y., Jo, E.-J., Eom, J. S., Mok, J., Kim, M.-H., Kim, K. U., Park, H.-K., Lee, M. K., & Lee, K. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.07.004 · Cited by 130
“Experimental studies show that acute administration of corticosteroids reduces inflammatory cytokine levels and decreases the bacterial burden in severe pneumonia [14, 40].”
BackgroundSchrepf, A., Clevenger, L., Christensen, D., DeGeest, K., Bender, D., Ahmed, A., Goodheart, M. J., Dahmoush, L., Penedo, F., Lucci, J. A., et al. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.07.022 · Cited by 127
“Cortisol is a glucocorticoid hormone released by the hypothalamic–pituitary–adrenal (HPA) axis in response to inflammation (Rhen and Cidlowski, 2005), stress and other stimuli (Chrousos and Gold, 1998), and serves as an important regulator of metabolic function.”
BackgroundLedderose, C., Möhnle, P., Limbeck, E., Schütz, S., Weis, F., Rink, J., Briegel, J., & Kreth, S. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31825b8ebc · Cited by 130
van Zuiden, M., Kavelaars, A., Geuze, E., Olff, M., & Heijnen, C. J. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.08.015 · Cited by 140
Sinha, A. P., & Bagga, A. (2008) · The Indian Journal of Pediatrics · doi:10.1007/s12098-008-0210-7 · Cited by 150
Inflammation and cortisol response in coronary artery disease
Nijm, J., & Jonasson, L. (2009) · Annals of Medicine · doi:10.1080/07853890802508934 · Cited by 128
“Two human isoforms of the GR have been identified, termed GR-a and GR-b, which originate from the same gene by alternative splicing of the GR primary transcript (27,32).”
BackgroundStaurengo‐Ferrari, L., Badaro‐Garcia, S., Hohmann, M. S., Manchope, M. F., Zaninelli, T. H., Casagrande, R., & Verri, W. A., Jr. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01536 · Cited by 133
“Adverse effects include osteoporosis, skin atrophy, diabetes, abdominal obesity, glaucoma, growth retardation in children, immunosuppression, inhibition of wound repair, and hypertension hypertension (Miner et al., 2005; Rhen and Cidlowski, 2005).”
BackgroundLocal delivery of corticosteroids in clinical ophthalmology: A review
Fung, A. T.-C., Tran, T., Lim, L. L., Samarawickrama, C., Arnold, J., Gillies, M. C., Catt, C. J., Mitchell, L., Symons, R. C. A., Buttery, R., et al. (2019) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13702 · Cited by 129
“These actions block the release of arachidonic acid and its subsequent eicosanoids (prostaglandins, thromboxanes, prostacyclins and leukotrienes).(5) This affects the”
BackgroundBiochemical Basis of Asthma Therapy
Barnes, P. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.206466 · Cited by 136
Glucocorticoid signaling in the heart: A cardiomyocyte perspective
Oakley, R. H., & Cidlowski, J. A. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.03.009 · Cited by 135
“Because of their potent anti-inflammatory and immunosuppressive actions, synthetic glucocorticoids comprise one of the most widely prescribed classes of drugs in the world today (5, 6).”
BackgroundSelf-citationCorticosteroid therapy in assisted reproduction – immune suppression is a faulty premise
Robertson, S. A., Jin, M., Yu, D., Moldenhauer, L. M., Davies, M. J., Hull, M. L., & Norman, R. J. (2016) · Human Reproduction · doi:10.1093/humrep/dew186 · Cited by 132
“Corticosteroid drugs mimic the endogenous glucocorticoid hormone cortisol that is released primarily from the adrenal cortex (Rhen and Cidlowski, 2005).”
BackgroundDang, T. T., Thai, A. V., Cohen, J., Slosberg, J. E., Siniakowicz, K., Doloff, J. C., Ma, M., Hollister-Lock, J., Tang, K. M., Gu, Z., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.016 · Cited by 125
What do DNA methylation studies tell us about depression? A systematic review
Li, M., D’Arcy, C., Li, X., Zhang, T., Joober, R., & Meng, X. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0412-y · Cited by 125
Brain-lung crosstalk: Implications for neurocritical care patients
Mrozek, S., Constantin, J., & Geeraerts, T. (2015) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v4.i3.163 · Cited by 137
Bello, L., Kesari, A., Gordish‐Dressman, H., Cnaan, A., Morgenroth, L. P., Punetha, J., Duong, T., Henricson, E., Pegoraro, E., McDonald, C. M., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24370 · Cited by 137
The role of the circadian clock in rheumatoid arthritis
Gibbs, J. E., & Ray, D. W. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4146 · Cited by 119
Kukreti, H., Amuthavalli, K., Harikumar, A., Sathiyamoorthy, S., Feng, P. Z., Anantharaj, R., Tan, S. L. K., Lokireddy, S., Bonala, S., Sriram, S., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.390369 · Cited by 121
“Glucocorticoids are used as therapeutic agents due to their potent anti-inflammatory and immunosuppressive functions (1).”
BackgroundAdvanced Strategies for Modulation of the Material–Macrophage Interface
Huyer, L. D., Pascual‐Gil, S., Wang, Y., Mandla, S., Yee, B., & Radisic, M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909331 · Cited by 127
Lunn, T. H., & Kehlet, H. (2013) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12115 · Cited by 125
Shipp, L. E., Lee, J. V., Yu, C.-Y., Pufall, M., Zhang, P., Scott, D. K., & Wang, J.-C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013754 · Cited by 121
“[1,2,3,4,5].”
Social Stress and Psychosis Risk: Common Neurochemical Substrates?
Mizrahi, R. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.274 · Cited by 135
Use of Corticosteroids in Treating Infectious Diseases
McGee, S. R., & Hirschmann, J. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.10.1034 · Cited by 134
“Corticosteroids decrease vascular permeability, inhibit leukocyte migration to sites of inflammation, andexert intracellular effects that block transcription of inflammatory proteins and encode anti-inflammatory proteins.(151,152) Corticosteroid therapy accelerated defervescence in several infections, alleviated throa…”
BackgroundRonacher, K., Hadley, K., Avenant, C., Stubsrud, E., Simons, S. S., Louw, A., & Hapgood, J. P. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.008 · Cited by 121
Inhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis
Hannan, T. J., Roberts, P. L., Riehl, T. E., van der Post, S., Binkley, J. M., Schwartz, D. J., Miyoshi, H., Mack, M., Schwendener, R. A., Hooton, T. M., et al. (2014) · EBioMedicine · doi:10.1016/j.ebiom.2014.10.011 · Cited by 123
“Dexamethasone also specifically inhibits the inflammation-dependent expression of cyclooxygenase-2 (COX-2), which catalyzes the ratelimiting step in the conversion of AA to prostanoids, i.e. prostaglandins and thromboxanes (Rhen and Cidlowski, 2005).”
Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study
Zakerska‐Banaszak, O., Tomczak, H., Gabryel, M., Baturo, A., Wolko, Ł., Michalak, M., Malińska, N., Mańkowska‐Wierzbicka, D., Eder, P., Dobrowolska, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81628-3 · Cited by 143
Corticosteroids for severe sepsis: an evidence-based guide for physicians
Annane, D. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-7 · Cited by 139
“None of the recent meta-analysis found differences in treatment benefits in nonresponders versus responders to the ACTH test [3-38].”
BackgroundResultSamarasinghe, R. A., Di Maio, R., Volonte, D., Galbiati, F., Lewis, M., Romero, G., & DeFranco, D. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102821108 · Cited by 120
Endothelial Response to Glucocorticoids in Inflammatory Diseases
Zielińska, K. A., Moortel, L. V., Opdenakker, G., Bosscher, K. D., & den Steen, P. E. V. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00592 · Cited by 132
“First, high therapeutic doses used to reach desired physiological effects also induce undesired side-effects including osteoporosis, diabetes, and hypertension (48, 54, 56).”
BackgroundInfluentialStress and innate immunity in carp: Corticosteroid receptors and pro-inflammatory cytokines
Stolte, E. H., Nabuurs, S. B., Bury, N. R., Sturm, A., Flik, G., Savelkoul, H. F. J., & Kemenade, B. M. L. V.-V. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.07.022 · Cited by 121
Isidori, A. M., Minnetti, M., Sbardella, E., Graziadio, C., & Grossman, A. B. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0308 · Cited by 130
The Pro-inflammatory Effects of Glucocorticoids in the Brain
Duque, E. D. A., & Munhoz, C. D. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00078 · Cited by 115
Cianchetti, S., Fiorentino, A. D., Colognato, R., Stefano, R. D., Franzoni, F., & Pedrinelli, R. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.09.013 · Cited by 125
Corticosteroids Reduce IL-6 in ASM Cells via Up-Regulation of MKP-1
Quante, T., Ng, Y. C., Ramsay, E. E., Henness, S., Allen, J. C., Parmentier, J., Ge, Q., & Ammit, A. J. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0014oc · Cited by 118
Newton, R., Leigh, R., & Giembycz, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.003 · Cited by 132
“Once in the nucleus, the DNA binding domain (DBD) of GR directs binding and receptor dimerization on near palindromic DNA sequences (Luisi et al., 1991), called simple glucocorticoid response elements (GREs) (Table 1) (Rhen & Cidlowski, 2005; Newton, 2000).”
Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure
Sheppard, J. D., Comstock, T. L., & Cavet, M. E. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0315-8 · Cited by 117
“By inhibiting upstream phospholipase A2, they block both the cyclooxygenase and lipoxygenase pathways of the inflammatory cascade and thus prevent formation of all eicosanoids [2, 3].”
BackgroundNippes, R. P., Macruz, P. D., da Silva, G. N., & Scaliante, M. H. N. O. (2021) · Process Safety and Environmental Protection · doi:10.1016/j.psep.2021.06.040 · Cited by 124
Invasive aspergillosis in glucocorticoid-treated patients
Lewis, R. E., & Kontoyiannis, D. P. (2009) · Medical Mycology · doi:10.1080/13693780802227159 · Cited by 113
“The effects of glucocorticoids on B-cells are mediated in part by reduction T-helper cell interactions required for antibody production [ 2 ].”
BackgroundInfluentialCellular mechanisms underlying steroid-resistant asthma
Wadhwa, R., Dua, K., Adcock, I. M., Horvat, J. C., Kim, R., & Hansbro, P. M. (2019) · European Respiratory Review · doi:10.1183/16000617.0096-2019 · Cited by 123
Corticosteroids in Respiratory Diseases in Children
de Benedictis, F. M., & Bush, A. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201107-1174ci · Cited by 133
Dexamethasone Inhibits Interleukin-1β-Induced Corneal Neovascularization
Nakao, S., Hata, Y., Miura, M., Noda, K., Kimura, Y. N., Kawahara, S., Kita, T., Hisatomi, T., Nakazawa, T., Jin, Y., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070172 · Cited by 120
“Corticosteroids inhibit inflammation through various different pathways.(20) For instance, corticosteroid-induced MAPK phosphatase 1 dephosphorylates and inactivates Jun N-terminal kinase, thereby inhibiting c-Jun-mediated transcription.”
BackgroundInfluentialCircadian depression: A mood disorder phenotype
Carpenter, J. S., Crouse, J. J., Scott, E. M., Naismith, S. L., Wilson, C., Scott, J., Merikangas, K. R., & Hickie, I. B. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.045 · Cited by 114
Hypersensitivity pneumonitis: Current concepts in pathogenesis, diagnosis, and treatment
Barnes, H., Troy, L. K., Lee, C. T., Sperling, A. I., Strek, M. E., & Glaspole, I. (2021) · Allergy · doi:10.1111/all.15017 · Cited by 117
Glucocorticoids in multiple myeloma: past, present, and future
Burwick, N. R., & Sharma, S. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3465-8 · Cited by 122
Martinez, G. J., Appleton, M., Kipp, Z. A., Loria, A. S., Min, B., & Hinds, T. D. (2023) · Physiological Reviews · doi:10.1152/physrev.00021.2023 · Cited by 118
Glucocorticoid Receptor Gene and Risk of Cardiovascular Disease
van den Akker, E. L. T. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.41 · Cited by 113
“Glucocorticoids exert their effect through the glucocorticoid receptor, which is expressed in most cells of the human body and regulates the expression of multiple genes.(5) The sensitivity to glucocorticoids varies considerably between individuals.”
BackgroundMucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease
Date, A. A., Halpert, G., Babu, T., Ortiz, J., Kanvinde, P. P., Dimitrion, P. M., Narayan, J., Zierden, H. C., Betageri, K. R., Musmanno, O., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.005 · Cited by 115
“homeostasis, by promoting a wound-healing and anti-inflammatory activity in macrophages, inducing neutrophil and T cell apoptosis and promoting the removal of apoptotic cells [45, 46].”
Kosseifi, S. G., Guha, B., Nassour, D. N., Chi, D. S., & Krishnaswamy, G. A. (2006) · Journal of Occupational Medicine and Toxicology · doi:10.1186/1745-6673-1-9 · Cited by 110
Liu, P. Z., & Nusslock, R. (2018) · Current Genomics · doi:10.2174/1389202919666171228164350 · Cited by 103
“As steroid receptors, GRs are located cytoplasmically, and upon binding with cortisol or other glucocorticoids, exert their regulatory effects in the HPA axis stress pathway through altering gene expression [26].”
BackgroundBellinger, D. L., & Lorton, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041188 · Cited by 115
“Therefore, the possibility that reduced circulating glucocorticoid levels significantly contributed to the pro-inflammatory response cannot be discounted [68,109].”
BackgroundUseful adjuvants for postoperative pain management
Buvanendran, A., & Kroin, J. S. (2007) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2006.12.003 · Cited by 134
Azzinnari, D., Sigrist, H., Staehli, S., Palme, R., Hildebrandt, T., Leparc, G., Hengerer, B., Seifritz, E., & Pryce, C. R. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.039 · Cited by 109
“…activation combined with an adrenal insufficiency that would dampen anti-inflammatory corticoid activity; this would predispose them to stress-induced activation of immune-inflammatory pathways and the pathological effects thereof (Rhen and Cidlowski, 2005; Silverman and Sternberg, 2012).”
Diurnal cortisol and survival in epithelial ovarian cancer
Schrepf, A., Thaker, P. H., Goodheart, M. J., Bender, D., Slavich, G. M., Dahmoush, L., Penedo, F., DeGeest, K., Mendez, L., Lubaroff, D. M., et al. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.01.010 · Cited by 102
“Cortisol, a glucocorticoid, is released into circulation by the adrenal cortex following upstream signaling from the pituitary and hypothalamus (Rhen & Cidlowski, 2005).”
Backgroundde la Motte, L., Kehlet, H., Vogt, K., Nielsen, C. H., Groenvall, J. B., Nielsen, H. B., Andersen, A., Schroeder, T. V., & Lönn, L. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000895 · Cited by 111
“6 1 (class 1 + 2) 26 (35) 30 (40) 2 (class 3 + 4) 49 (65) 45 (60) Duration of surgery, h 1:41 (1:18–2:12) 1:27 (1:10–2:03) 0.”
Metadata
- Authors
- Rhen, T., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-10-20
- Volume
- 353
- Issue
- 16
- Pages
- 1711-1723
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150691073
- Cited by
- 3,149
- References
- 93
- Citations by year
- 2026: 123 · 2025: 122 · 2024: 152 · 2023: 155 · 2022: 188 · 2021: 220 · 2020: 214 · 2019: 164 · 2018: 153 · 2017: 173 · 2016: 183 · 2015: 176 · 2014: 163 · 2013: 167 · 2012: 136
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- glucocorticoids, anti-inflammatory mechanism, inflammation, glucocorticoid adverse effects, drug mechanisms of action
- MeSH terms
- Anti-Inflammatory Agents, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.